Crossmark Global Holdings’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Buy
3,191
+51
+2% +$8.5K 0.01% 870
2026
Q1
$659K Sell
3,140
-128
-4% -$32.2K 0.01% 746
2025
Q4
$929K Buy
3,268
+384
+13% +$120K 0.01% 629
2025
Q3
$890K Buy
2,884
+23
+0.8% +$7.21K 0.01% 669
2025
Q2
$899K Sell
2,861
-175
-6% -$50.5K 0.01% 659
2025
Q1
$797K Buy
3,036
+100
+3% +$27.1K 0.01% 681
2024
Q4
$767K Sell
2,936
-197
-6% -$49.6K 0.01% 663
2024
Q3
$730K Sell
3,133
-344
-10% -$70.6K 0.01% 710
2024
Q2
$702K Buy
3,477
+196
+6% +$35.3K 0.01% 705
2024
Q1
$563K Sell
3,281
-115
-3% -$21.4K 0.01% 812
2023
Q4
$737K Sell
3,396
-435
-11% -$74.6K 0.02% 698
2023
Q3
$560K Sell
3,831
-213
-5% -$47.7K 0.01% 768
2023
Q2
$1.14M Buy
4,044
+370
+10% +$112K 0.02% 555
2023
Q1
$1.17M Buy
+3,674
New +$1.09M 0.03% 536

Other funds holding PODD

Crossmark Global Holdings's PODD Position: Q2 2026 in Review

Crossmark Global Holdings increased its Insulet (PODD) stake by 1.6% in Q2 2026, buying an estimated $8.5K and bringing the position to 3,191 shares worth $486K. The position accounts for 0.01% of the portfolio, ranked #870.

Crossmark Global Holdings first reported a position in PODD in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.17M in Q1 2023. 77 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Crossmark Global Holdings held 3,191 shares of Insulet worth $486K as of Q2 2026.
  • Crossmark Global Holdings bought 51 Insulet shares in Q2 2026, an estimated $8.5K.
  • Insulet made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #870 holding.
  • Crossmark Global Holdings first reported a position in Insulet in Q1 2023 and has held it in 14 quarters since.
  • Crossmark Global Holdings's Insulet position peaked at $1.17M in Q1 2023.
  • 77 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.